Protocol for an Effectiveness-Implementation Hybrid Trial to Evaluate Scale up of an Evidence-Based Intervention Addressing Lifestyle Behaviours From the Start of Life: INFANT.
child obesity prevention
implementation science
infants (birth to 2 years)
nutrition
obesity
physical activity
scaling up
sedentary behavior
Journal
Frontiers in endocrinology
ISSN: 1664-2392
Titre abrégé: Front Endocrinol (Lausanne)
Pays: Switzerland
ID NLM: 101555782
Informations de publication
Date de publication:
2021
2021
Historique:
received:
31
05
2021
accepted:
21
09
2021
entrez:
3
1
2022
pubmed:
4
1
2022
medline:
12
2
2022
Statut:
epublish
Résumé
Promoting healthy eating and active play in early life is critical, however few interventions have been delivered or sustained at scale. The evaluation of interventions at scale is a crucial, yet under-researched aspect of modifying population-level health behaviours. INFANT is an evidence-based early childhood healthy lifestyle intervention that aims to improve parents' knowledge and skills around promoting optimal energy balance-related behaviours that, in turn, influence children's diet, activity and adiposity. It consists of: 1) Four group sessions delivered via first time parent groups across the first 12 months of life; 2) access to the My Baby Now app from birth to 18 months of age. This research aims to assess real-world implementation, effectiveness and cost-effectiveness of INFANT when delivered at scale across Victoria, Australia. A hybrid type II implementation-effectiveness trial applying a mixed methods design will be conducted. INFANT will be implemented in collaboration with practice and policy partners including maternal and child health services, population health and Aboriginal health, targeting all local government areas (n=79) in Victoria, Australia. Evaluation is based on criteria from the 'Outcomes for Implementation Research' and 'RE-AIM' frameworks. Implementation outcomes will be assessed using descriptive quantitative surveys and qualitative interviews with those involved in implementation, and include intervention reach, organisational acceptability, adoption, appropriateness, cost, feasibility, penetration and sustainability. Process measures include organizational readiness, fidelity, and adaptation. Effectiveness outcomes will be assessed using a sample of INFANT participants and a non-randomized comparison group receiving usual care (1,500 infants in each group), recruited within the same communities. Eligible participants will be first time primary caregivers of an infant aged 0-3 months, owning a personal mobile phone and able to communicate in English. Effectiveness outcomes include infant lifestyle behaviours and BMIz at 12 and 18 months of age. This is the first known study to evaluate the scale up of an evidence based early childhood obesity prevention intervention under real world conditions. This study has the potential to provide generalisable implementation, effectiveness and cost-effectiveness evidence to inform the future scale up of public health interventions both in Australia and internationally. Australian and New Zealand Clinical Trial Registry https://www.anzctr.org.au/, identifier ACTRN12620000670976.
Identifiants
pubmed: 34975744
doi: 10.3389/fendo.2021.717468
pmc: PMC8715861
doi:
Banques de données
ANZCTR
['ACTRN12620000670976']
Types de publication
Clinical Trial Protocol
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
717468Informations de copyright
Copyright © 2021 Laws, Love, Hesketh, Koorts, Denney-Wilson, Moodie, Brown, Ong, Browne, Marshall, Lioret, Orellana and Campbell.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Transl Behav Med. 2019 Jul 16;9(4):759-767
pubmed: 30011024
Prev Chronic Dis. 2014 Jan 23;11:130184
pubmed: 24456645
Pediatrics. 2013 Apr;131(4):652-60
pubmed: 23460688
Health Promot Int. 2016 Sep;31(3):614-22
pubmed: 25769978
Prev Med. 2014 Jan;58:58-63
pubmed: 24201090
JMIR Mhealth Uhealth. 2017 Dec 18;5(12):e196
pubmed: 29254908
Med Care Res Rev. 2012 Apr;69(2):123-57
pubmed: 22203646
Am J Prev Med. 2012 May;42(5):437-44
pubmed: 22516482
BMC Public Health. 2016 Aug 08;16:748
pubmed: 27502184
Nutrients. 2020 Mar 09;12(3):
pubmed: 32182889
JMIR Mhealth Uhealth. 2018 Apr 19;6(4):e78
pubmed: 29674313
Nutrients. 2018 Apr 19;10(4):
pubmed: 29671815
PLoS One. 2020 Mar 25;15(3):e0230669
pubmed: 32210467
Eur J Clin Nutr. 2013 Mar;67(3):275-81
pubmed: 23321573
BMC Public Health. 2008 Mar 31;8:103
pubmed: 18373877
Curr Obes Rep. 2015 Sep;4(3):350-62
pubmed: 26627493
PLoS One. 2020 Jun 19;15(6):e0234804
pubmed: 32559212
Public Health Res Pract. 2017 Oct 11;27(4):
pubmed: 29114712
Lancet. 2011 Aug 27;378(9793):826-37
pubmed: 21872751
Implement Sci. 2013 Dec 01;8:139
pubmed: 24289295
Pediatrics. 2014 Sep;134(3):e846-7
pubmed: 25157019
JMIR Mhealth Uhealth. 2017 Jun 29;5(6):e89
pubmed: 28663164
Implement Sci. 2009 Aug 07;4:50
pubmed: 19664226
Implement Sci. 2019 Jun 6;14(1):58
pubmed: 31171014
Med Care. 2012 Mar;50(3):217-26
pubmed: 22310560
Int J Obes (Lond). 2015 Jul;39(7):1079-85
pubmed: 25907316
BMJ. 2015 Feb 06;350:h391
pubmed: 25662947
Obes Rev. 2018 Mar;19(3):321-332
pubmed: 29052309
Obes Rev. 2016 Mar;17(3):276-95
pubmed: 26693831
Health Promot Int. 2013 Sep;28(3):285-98
pubmed: 22241853
Adm Policy Ment Health. 2011 Mar;38(2):65-76
pubmed: 20957426
Int J Behav Nutr Phys Act. 2020 Jul 25;17(1):95
pubmed: 32711523
Front Public Health. 2019 Mar 29;7:64
pubmed: 30984733
Br J Nutr. 2012 Aug;108(3):518-26
pubmed: 22040598
Res Social Adm Pharm. 2017 Sep - Oct;13(5):1028-1035
pubmed: 28356213
Implement Sci. 2015 Feb 12;10:21
pubmed: 25889199
Public Health Nutr. 2021 Apr;24(6):1460-1468
pubmed: 33427160
Implement Sci. 2018 Aug 7;13(1):109
pubmed: 30086782
BMC Public Health. 2016 Feb 18;16:166
pubmed: 26888759